Disparities in survival after trimodality therapy for esophageal adenocarcinoma
{{output}}
Trimodality therapy with neoadjuvant chemoradiation followed by surgery has emerged as the standard of care for the treatment of locally advanced esophageal cancer. Yet, there is considerable variation in survival within this population. We sought to analyze f... ...